Sensex 27371.84 245.27 0.9%
Nifty 8225.2 65.9 0.81%
India Infoline News Service | Mumbai December 18, 2014 12:44 IST
Earlier Exchange has sought clarification from Lupin Ltd with respect to news article appearing in Economic Times on December 15, 2014 titled "Scouting for Acquisitions"
capital market | Mumbai December 17, 2014 17:24 IST
Of Rs 2 each
India Infoline News Service | Mumbai December 15, 2014 09:56 IST
Report stated that the company is looking at ramping up its India business, with new product launches.
India Infoline News Service | Mumbai December 12, 2014 12:36 IST
The stock is now trading with a gain of 1.4 per cent.
capital market | Mumbai December 11, 2014 12:42 IST
Lupin gained 0.77% to Rs 1,441.95 at 13:00 IST on BSE after the company announced that its US subsidiary launched the authorized generic for G.D. Searle LLC's Celebrex Capsules.
India Infoline News Service | Mumbai December 11, 2014 12:28 IST
At 12.30 PM, the stock was up 0.43% at Rs. 6.20.
capital market | Mumbai November 24, 2014 12:01 IST
Lupin rose 1.22% to Rs 1,482 at 12:01 IST on BSE on reports a government panel has cleared the company's request to raise foreign investment limit in the firm.
capital market | Mumbai November 19, 2014 11:04 IST
Under stock option plan
India Infoline News Service | Mumbai November 03, 2014 13:18 IST
Lupin is the 5th largest and fastest growing top 5 generics player in the US.
capital market | Mumbai November 03, 2014 12:37 IST
India Infoline Research Team | Mumbai October 30, 2014 17:21 IST
Lupin reported a subdued quarter on sequential basis on the back of a stellar Q1 as revenues declined 5% qoq (+~19% yoy) vs our estimate of +0.2% qoq and 25.4% yoy.
India Infoline News Service | Mumbai October 30, 2014 09:11 IST
Strong growth prospects in other territories and an improved margin profile make Lupin one of our best picks in large-cap pharma space
capital market | Mumbai October 29, 2014 13:15 IST
US business declined on QoQ basis
capital market | Mumbai October 28, 2014 16:52 IST
Sales rise 3.77% to Rs 2207.48 crore
India Infoline News Service | Mumbai October 28, 2014 16:18 IST
Lupin closed down 2.45% at Rs.1,359 on NSE as against the previous close of Rs. 1,358
capital market | Mumbai October 28, 2014 14:29 IST
Lupin slipped 1.65% to Rs 1,371.10 at 14:25 IST on BSE, in volatile trade after announcing Q2 result during market hours today, 28 October 2014.
capital market | Mumbai October 28, 2014 13:53 IST
Lupin fell 1.29% to Rs 1,376 at 13:45 IST on BSE, with the stock extending intraday fall in volatile trade after announcing Q2 result during market hours today, 28 October 2014.
India Infoline News Service | Mumbai October 28, 2014 13:47 IST
The net profit of the pharma company increased to Rs 630 crore as against Rs. 406 crore in the same quarter last fiscal.
India Infoline News Service | Mumbai October 28, 2014 13:38 IST
At 1:37PM, Lupin was trading down 1% at Rs. 1379 as against the previous close of Rs. 1394
India Infoline News Service / 11:47, Dec 12, 2014
Stepping into a new life comes with a multitude of responsibilities Therefore, it is important to include your spouse in your monetary affairs at the earliest in order to be on common grounds financially.